图加福雷斯托利德 (Tsugaforrestolide) 是一种来自易受伤害的针叶树图加福雷斯蒂 (Tsuga forrestii) 的抗炎性比萨博兰类型的赛斯基烯乳
Peng-Jun Zhou1,2,3, Ze-Yu Zhao1,3, Zhe-Lu Jiang1
1Key Laboratory of Endangered Plants Sustainable Utilization of Taizhou, Institute of Natural Medicine and Health Products, School of Pharmaceutical Sciences, Taizhou University, Zhejiang, People's Republic of China.
Chemistry & biodiversity
|November 20, 2025
概括
一种新型的基,tsugaforrestolide,从福雷斯特的中分离出来. 这种化合物通过抑制巨细胞中氧化的产生,显示出显著的抗炎作用.
科学领域:
- 植物化学 植物化学
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 松树 (Tsuga forrestii) 是一种易受伤害的针叶树,众所周知可以产生多种不同的二.
- 之前的植物化学研究没有报告来自该物种的石.
研究的目的:
- 从Tsuga forrestii中分离和描述一个以前未被描述的基烯.
- 为了评估隔离化合物的抗炎潜力.
主要方法:
- 使用光谱技术 (NMR,ECD) 和计算分析 (GIAO NMR,DP4+) 阐明结构.
- 单晶X射线衍射用于绝对配置的确定.
- 在RAW 264.7巨细胞中使用脂聚糖 (LPS) 诱导的氧化 (NO) 生产的体外抗炎试验.
主要成果:
- 一种新的C-15碳氧化比萨博兰类型的基,tsugaforrestolide (1),具有12,9-lactone部分,被分离和结构阐明.
- 图加福雷斯托利德 (1) 在RAW 264.7巨细胞中显著抑制了LPS诱导的NO产生 (IC50=7.1μM).
- 抗炎活性与已知的抑制剂BAY11-7082 (IC50 = 8.7μM) 相比.
结论:
- 图加福雷斯托利德是第一种从鱼物种中报告的类类,突出显示了新的化学多样性.
- 该化合物表现出有希望的抗炎性质,表明其具有治疗潜力.
- 保护Tsuga forrestii对于发现和利用有价值的自然产品至关重要.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K

